SEC Company Response from HARVARD BIOSCIENCE (HBIO) — Feb 5, 2026
HARVARD BIOSCIENCE INC
Date: Feb. 5, 2026 · CIK: 0001123494 · Accession: 0001171843-26-000653
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-293099
Letter
Re: Harvard Bioscience, Inc.
February 5, 2026
Via EDGAR
U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549
Attn: Margaret Sawicki
Registration Statement on Form S-3 (the "Registration Statement")
File No. 333-293099
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Harvard Bioscience, Inc. (the "Company") hereby respectfully requests that the effective date of the above-referenced Registration Statement be accelerated to 10 a.m., Eastern Time, on February 9, 2026, or as soon as practicable thereafter.
Please contact Sarah C. Griffiths of Covington & Burling LLP at (617) 603-8815 or sgriffiths@cov.com with any questions you may have regarding this request. In addition, please notify Ms. Griffiths by telephone when this request for acceleration has been granted.
Very truly yours,
HARVARD BIOSCIENCE, INC.
Show Raw Text
CORRESP 1 filename1.htm February 5, 2026 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attn: Margaret Sawicki Re: Harvard Bioscience, Inc. Registration Statement on Form S-3 (the "Registration Statement") File No. 333-293099 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Harvard Bioscience, Inc. (the "Company") hereby respectfully requests that the effective date of the above-referenced Registration Statement be accelerated to 10 a.m., Eastern Time, on February 9, 2026, or as soon as practicable thereafter. Please contact Sarah C. Griffiths of Covington & Burling LLP at (617) 603-8815 or sgriffiths@cov.com with any questions you may have regarding this request. In addition, please notify Ms. Griffiths by telephone when this request for acceleration has been granted. Very truly yours, HARVARD BIOSCIENCE, INC. By: /s/ Mark Frost Name: Mark Frost Title: Interim Chief Financial Officer cc: Megan Gates, Covington & Burling LLP Sarah C. Griffiths, Covington & Burling LLP